Surprise: Des-Acyl Ghrelin Is Actually a Full Agonist at the Ghrelin Receptor, Not Inactive

Unacylated (des-acyl) ghrelin unexpectedly functioned as a full agonist at the GHS-R1a receptor (previously thought to be inactive at this receptor), challenging the assumption that only acylated ghrelin has GHS-R activity.

Gauna, Carlotta et al.·Molecular and cellular endocrinology·2007·Preliminary Evidencein-vitro
RPEP-01229In VitroPreliminary Evidence2007RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
in-vitro
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Des-acyl ghrelin, previously considered inactive at GHS-R1a, demonstrated full agonist activity at the type 1a receptor — challenging the fundamental assumption that only acylated ghrelin has GHS-R activity and redefining des-acyl ghrelin's biological role.

Key Numbers

How They Did This

in-vitro study on ghrp, receptor-signaling.

Why This Research Matters

Relevant for ghrp, receptor-signaling.

The Bigger Picture

Advances peptide research.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.
  • ?Clinical translation to evaluate.

Trust & Context

Key Stat:
Key finding Des-acyl ghrelin, previously considered inactive at GHS-R1a, demonstrated full agonist activity at the type 1a receptor — challenging the fundamental
Evidence Grade:
preliminary evidence.
Study Age:
Published in 2007.
Original Title:
Unacylated ghrelin is not a functional antagonist but a full agonist of the type 1a growth hormone secretagogue receptor (GHS-R).
Published In:
Molecular and cellular endocrinology, 274(1-2), 30-4 (2007)
Database ID:
RPEP-01229

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What was studied?

Surprise: Des-Acyl Ghrelin Is Actually a Full Agonist at the Ghrelin Receptor, Not Inactive

What was found?

Unacylated (des-acyl) ghrelin unexpectedly functioned as a full agonist at the GHS-R1a receptor (previously thought to be inactive at this receptor), challenging the assumption that only acylated ghrelin has GHS-R activity.

Read More on RethinkPeptides

Cite This Study

RPEP-01229·https://rethinkpeptides.com/research/RPEP-01229

APA

Gauna, Carlotta; van de Zande, Bedette; van Kerkwijk, Anke; Themmen, Axel P N; van der Lely, A J; Delhanty, Patric J D. (2007). Unacylated ghrelin is not a functional antagonist but a full agonist of the type 1a growth hormone secretagogue receptor (GHS-R).. Molecular and cellular endocrinology, 274(1-2), 30-4.

MLA

Gauna, Carlotta, et al. "Unacylated ghrelin is not a functional antagonist but a full agonist of the type 1a growth hormone secretagogue receptor (GHS-R).." Molecular and cellular endocrinology, 2007.

RethinkPeptides

RethinkPeptides Research Database. "Unacylated ghrelin is not a functional antagonist but a full..." RPEP-01229. Retrieved from https://rethinkpeptides.com/research/gauna-2007-unacylated-ghrelin-is-not

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.